ClinicalTrialExchange
  • Home
  • For Patients
  • For Professionals
  • About
  • Contact

Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Pathologic Complete Response

  • Phase II Study Evaluating the Efficacy and Safety of the Combination of Tagraxofusp and Venetoclax in Treatment-naive Blastic Plasmacytoid Dendritic Cell Neoplasm Patients
  • SHR-A1811 Plus Pertuzumab in the Neoadjuvant Treatment of HER2 Positive BC
  • Two-cycle and Three-cycle Induction Therapy With Modified TPF Regimen Combined and Camrelizumab for LANPC
  • Impact Of Metformin In Rectal Cancer Patients
  • Neoadjuvant Inhaled Azacytidine With Platinum-Based Chemotherapy and Durvalumab (MEDI4736) - a Combined Epigenetic-Immunotherapy (AZA-AEGEAN) Regimen for Operable Early-Stage Non-Small Cell Lung Cancer (NSCLC)
  • Neoadjuvant Chemotherapy and PD-1 Inhibitor for Locally Advanced Rectal Cancer
  • Darsilide Combined With AI, Trastuzumab and Patuzumab in the Neoadjuvant Treatment of HR+/HER2+ Breast Cancer
© Copyright 2002-2025 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies

Clinical Trials data from clinicaltrials.gov

Powered by DrugPatentWatch.

  • About
  • Contact
  • Follow ClinicalTrialsExchange:

      ClinicalTrialsExchange Linkedin Group